Compare COSMOS Pharmaceutical Corp. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 2.72% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate 2.72% of over the last 5 years
3
The company has declared Negative results for the last 12 consecutive quarters
4
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.05%
0%
7.05%
6 Months
-6.17%
0%
-6.17%
1 Year
-27.13%
0%
-27.13%
2 Years
-12.39%
0%
-12.39%
3 Years
-60.05%
0%
-60.05%
4 Years
-53.93%
0%
-53.93%
5 Years
-68.4%
0%
-68.4%
COSMOS Pharmaceutical Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.84%
EBIT Growth (5y)
2.72%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
3.60
Tax Ratio
26.68%
Dividend Payout Ratio
17.91%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
15.74%
ROE (avg)
12.58%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.75
EV to EBIT
12.25
EV to EBITDA
7.72
EV to Capital Employed
1.70
EV to Sales
0.47
PEG Ratio
3.09
Dividend Yield
NA
ROCE (Latest)
13.87%
ROE (Latest)
11.48%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Aug 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - May'26 - QoQ
May'26
Nov'25
Change(%)
Net Sales
289,203.00
264,781.00
9.22%
Operating Profit (PBDIT) excl Other Income
16,946.00
15,002.00
12.96%
Interest
257.00
107.00
140.19%
Exceptional Items
-114.00
-103.00
-10.68%
Consolidate Net Profit
9,298.00
6,477.00
43.55%
Operating Profit Margin (Excl OI)
35.70%
34.10%
0.16%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - May'26
May'26
May'25
Change(%)
Net Sales
1,099,583.00
1,011,390.00
8.72%
Operating Profit (PBDIT) excl Other Income
66,929.00
62,633.00
6.86%
Interest
581.00
254.00
128.74%
Exceptional Items
-164.00
-278.00
41.01%
Consolidate Net Profit
32,046.00
30,978.00
3.45%
Operating Profit Margin (Excl OI)
38.50%
39.90%
-0.14%
USD in Million.
Net Sales
YoY Growth in year ended May 2026 is 8.72% vs 4.81% in May 2025
Consolidated Net Profit
YoY Growth in year ended May 2026 is 3.45% vs 26.68% in May 2025
About COSMOS Pharmaceutical Corp. 
COSMOS Pharmaceutical Corp.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






